Dr. Sina Bavari is the co-founder of Healion Bio. He is the lead (non-gov) scientific adviser to the World Health Organization on COVID-19. He has spent over 30 years developing rapid response prophylaxis, therapeutics and vaccines to some of the World’s deadliest infectious diseases.
Prior to co-founding Healion Bio, Sina was the Chief Scientific Officer and Scientific Director at USAMRIID (US Army Research Institute of Infectious Diseases), where he spent over twenty years leading the discovery and development of countermeasures for diseases such as Ebola, Marburg, Zika, Smallpox, Sudan, Nipah, alpha viruses, Anthrax and many others. He has worked extensively with the FDA to successfully develop clinically proven vaccines and therapeutics for many so-called envelope viruses like COVID-19.
Sina has published over 300 scientific papers and contributed to ~15 drug development candidates, 30 patent and many IND filings. His work has been published in many of the leading scientific journals including Nature, Nature Medicine, Cell, Cell Hosts, New England Journal of Medicine and many others. He has degrees from USC, and the University of Nebraska where he received his PhD in Immunotoxicology and Pharmaceutical Science.